Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
The MDL centers on allegations that drugs such as Ozempic, Wegovy, and related GLP-1 therapies can cause non-arteritic anterior ischemic optic neuropathy (NAION), a rare but serious condition that may result in abrupt and permanent vision impairment
Proximity picks the region
By leveraging telehealth, compounded pharmacies, and manufacturer programs, the article highlights options ranging from $99 to $399 per month
Reported effects include less bloating after meals and a more predictable digestive rhythm
Source: Polaris Market Research Analysis Industry Developments February 2025: Biocon launched its GLP-1 peptide liraglutide in the UK under two brand names: Liraglutide Biocon (for diabetes, similar to Victoza) and Biolide (for chronic weight management, similar to Saxenda)
US$ 21.18
US$ 26.91
US$ 25.81
US$ 25.22
US$ 27.46
